Adelaide Eye and Retina Centre | Adelaide, South Australia

Research site

(Unclaimed)

Location

18 North Terrace, Adelaide, South Australia, Australia

Site insights

Top conditions

Top treatments

KHK4951

Dexamethasone

BI 765128

Lampalizumab

ascorbic acid

Faricimab

EXN407

Aflibercept

STL303

JNJ-81201887

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 16 total trials

A Study in Adults With Geographic Atrophy

The purpose of this clinical research study is to look at how safe STL303 is and whether it works when given to people with Geographic Atrophy (GA) s...

Not yet enrolling

Geographic Atrophy

Drug: Placebo

Drug: STL303

A Study of CA201A Eye Drops to Prevent Corneal Endothelial Cell Loss in Patients Undergoing Cataract Surgery

This study is designed to assess whether an investigational eye drop called CA201A can help protect the cornea (the outer covering of the eye) and re...

Enrolling

Corneal Endothelial Cell Loss

Corneal Endothelial Damage Following the Hard Nuclear Cataract Surgery

Drug: Ascorbic acid ophthalmic solution 5%

Drug: Ophthalmic solution (matching formulation without ascorbic acid)

A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (CONSTANCE)

This study is a Phase IIIb/IV, multicenter, randomized, two-arm, open-label 100-week study to investigate the efficacy, safety, and durability of int...

Active, not recruiting

Neovascular Age-related Macular Degeneration (nAMD)

Drug: Faricimab